Tainan, Taiwan

Wen-Yen Yeh

This inventor holds 1 USPTO granted patent. Top assignee: Standard Chem. & Pharm. Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen-Yen Yeh. Retrieved from https://idiyas.com/inventor/wen-yen-yeh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Wen-Yen Yeh

Introduction

Wen-Yen Yeh is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on morphinan derivatives.

Latest Patents

Wen-Yen Yeh holds a patent for "Glycyrrhizinates of morphinan derivatives." This invention provides a pharmaceutically acceptable compound that includes a salt of a basic group-containing morphinan derivative and a carboxyl group-containing glycyrrhizinic acid. The compound has potential applications in manufacturing medicaments for treating and preventing cough, ameliorating pains, and addressing various diseases, including respiratory, cardiovascular, and liver diseases.

Career Highlights

Wen-Yen Yeh is associated with Standard Chem. & Pharm. Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating new pharmaceutical solutions that can improve patient outcomes.

Collaborations

Wen-Yen Yeh collaborates with talented individuals in his field, including Chin-Tsai Fan and Cheng-Shun Lai. These partnerships enhance the innovative capacity of his projects and contribute to the success of their endeavors.

Conclusion

Wen-Yen Yeh's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through scientific advancements. His work on morphinan derivatives is a testament to the potential of innovative research in addressing critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…